Purpose Group B Coxsackieviruses (CVB) include 6 serotypes (B1‐6) responsible for a wide range of clinical diseases. Since no recent seroepidemiologic data are available in Italy, the study aim was to investigate CVB seroprevalence in a wide Italian population. Methods The study retrospectively included 2,459 subjects referring to a large academic hospital in Rome (Italy) in the period 2004‐2016. Seroprevalence rates and neutralizing antibodies (nAb) titers were evaluated in relation to years of observation and subjects’ characteristics. Results Positivity for at least one serotype was detected in 69.1% of individuals. Overall, the prevalent serotype was B4, followed by B3 (33.3%), B5 (26.2%), B1 (12.7%), B2 (11.0%), and B6 (1.7%). For B2, a significant decrease in seroprevalence over years was observed. Positivity to at least one virus was 25.2% in children aged 0‐2 years, but significantly increased in pre‐school (3‐5 yr) (50.3%) and school (6‐10 yr) children (70.4%). Higher nAb responses for B3 and B4 were observed in children aged 3‐5 years. Conclusion A high overall CVB prevalence was found. Type‐specific variations in prevalence over time probably reflect the fluctuations in circulation typical of Enteroviruses. Children are at greater risk for CVB infection given the high number of seronegative subjects aged 0‐10 years.
Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population / Sciandra, Ilaria; Falasca, Francesca; Maida, Paola; Tranquilli, Giulia; Di Carlo, Daniele; Mazzuti, Laura; Melengu, Taulant; Giannelli, Gianluigi; Antonelli, Guido; Turriziani, Ombretta. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - (2020). [10.1002/jmv.26096]
Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population
Sciandra, Ilaria;Falasca, Francesca;Maida, Paola;Di Carlo, Daniele;Mazzuti, Laura;Melengu, Taulant;Antonelli, Guido;Turriziani, Ombretta
2020
Abstract
Purpose Group B Coxsackieviruses (CVB) include 6 serotypes (B1‐6) responsible for a wide range of clinical diseases. Since no recent seroepidemiologic data are available in Italy, the study aim was to investigate CVB seroprevalence in a wide Italian population. Methods The study retrospectively included 2,459 subjects referring to a large academic hospital in Rome (Italy) in the period 2004‐2016. Seroprevalence rates and neutralizing antibodies (nAb) titers were evaluated in relation to years of observation and subjects’ characteristics. Results Positivity for at least one serotype was detected in 69.1% of individuals. Overall, the prevalent serotype was B4, followed by B3 (33.3%), B5 (26.2%), B1 (12.7%), B2 (11.0%), and B6 (1.7%). For B2, a significant decrease in seroprevalence over years was observed. Positivity to at least one virus was 25.2% in children aged 0‐2 years, but significantly increased in pre‐school (3‐5 yr) (50.3%) and school (6‐10 yr) children (70.4%). Higher nAb responses for B3 and B4 were observed in children aged 3‐5 years. Conclusion A high overall CVB prevalence was found. Type‐specific variations in prevalence over time probably reflect the fluctuations in circulation typical of Enteroviruses. Children are at greater risk for CVB infection given the high number of seronegative subjects aged 0‐10 years.File | Dimensione | Formato | |
---|---|---|---|
Sciandra_Seroprevalence-group_2020.pdf
accesso aperto
Tipologia:
Documento in Pre-print (manoscritto inviato all'editore, precedente alla peer review)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
260.14 kB
Formato
Adobe PDF
|
260.14 kB | Adobe PDF | Visualizza/Apri PDF |
Sciandra_Seroprevalence-group_2020.pdf
Open Access dal 01/06/2021
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.11 MB
Formato
Adobe PDF
|
1.11 MB | Adobe PDF | Visualizza/Apri PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.